Literature DB >> 25503433

Neurocognitive Deficits After Radiation Therapy for Brain Malignancies.

Shumaila Saad1, Tony J C Wang.   

Abstract

Radiotherapy (RT) has proven to be an effective therapeutic tool in treatment of a wide variety of brain tumors; however, it has a negative impact on quality of life and neurocognitive function. Cognitive dysfunction associated with both the disease and adverse effects of RT is one of the most concerning complication among long-term survivors. The effects of RT to brain can be divided into acute, early delayed, and late delayed. It is, however, the late delayed effects of RT that lead to severe neurological consequences such as minor-to-severe cognitive deficits due to irreversible focal or diffuse necrosis of brain parenchyma. In this review, we discuss current and emerging data regarding the relationship between RT and neurocognitive outcomes, and therapeutic strategies to prevent/treat postradiation neurocognitive deficits.

Entities:  

Mesh:

Year:  2015        PMID: 25503433     DOI: 10.1097/COC.0000000000000158

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  27 in total

1.  RIP1 and RIP3 complex regulates radiation-induced programmed necrosis in glioblastoma.

Authors:  Arabinda Das; Daniel G McDonald; Yaenette N Dixon-Mah; Dustin J Jacqmin; Vikram N Samant; William A Vandergrift; Scott M Lindhorst; David Cachia; Abhay K Varma; Kenneth N Vanek; Naren L Banik; Joseph M Jenrette; Jeffery J Raizer; Pierre Giglio; Sunil J Patel
Journal:  Tumour Biol       Date:  2015-12-18

2.  Cerebral Cortex Regions Selectively Vulnerable to Radiation Dose-Dependent Atrophy.

Authors:  Tyler M Seibert; Roshan Karunamuni; Samar Kaifi; Jeffrey Burkeen; Michael Connor; Anitha Priya Krishnan; Nathan S White; Nikdokht Farid; Hauke Bartsch; Vyacheslav Murzin; Tanya T Nguyen; Vitali Moiseenko; James B Brewer; Carrie R McDonald; Anders M Dale; Jona A Hattangadi-Gluth
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-01-06       Impact factor: 7.038

3.  Radiation Dose-Dependent Hippocampal Atrophy Detected With Longitudinal Volumetric Magnetic Resonance Imaging.

Authors:  Tyler M Seibert; Roshan Karunamuni; Hauke Bartsch; Samar Kaifi; Anitha Priya Krishnan; Yoseph Dalia; Jeffrey Burkeen; Vyacheslav Murzin; Vitali Moiseenko; Joshua Kuperman; Nathan S White; James B Brewer; Nikdokht Farid; Carrie R McDonald; Jona A Hattangadi-Gluth
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-10-31       Impact factor: 7.038

4.  Altered Network Topology in Patients with Primary Brain Tumors After Fractionated Radiotherapy.

Authors:  Naeim Bahrami; Tyler M Seibert; Roshan Karunamuni; Hauke Bartsch; AnithaPriya Krishnan; Nikdokht Farid; Jona A Hattangadi-Gluth; Carrie R McDonald
Journal:  Brain Connect       Date:  2017-06

Review 5.  The quality of measurement properties of neurocognitive assessment in brain tumor clinical trials over the last 30 years: a COSMIN checklist-based approach.

Authors:  Maria De Martino; Barbara Santini; Giovanna Cappelletti; Annapina Mazzotta; Matteo Rasi; Giorgia Bulgarelli; Luciano Annicchiarico; Alessandro Marcocci; Andrea Talacchi
Journal:  Neurol Sci       Date:  2020-07-12       Impact factor: 3.307

6.  4π plan optimization for cortical-sparing brain radiotherapy.

Authors:  Vyacheslav L Murzin; Kaley Woods; Vitali Moiseenko; Roshan Karunamuni; Kathryn R Tringale; Tyler M Seibert; Michael J Connor; Daniel R Simpson; Ke Sheng; Jona A Hattangadi-Gluth
Journal:  Radiother Oncol       Date:  2018-03-05       Impact factor: 6.280

7.  Long-term cognitive dysfunction after radiation therapy for primary brain tumors.

Authors:  Lene Haldbo-Classen; Ali Amidi; Lisa M Wu; Slavka Lukacova; Gorm von Oettingen; Hanne Gottrup; Robert Zachariae; Morten Høyer
Journal:  Acta Oncol       Date:  2019-02-13       Impact factor: 4.089

8.  Feasibility of hippocampal dose-volume parameters associated with memory decline in intensity-modulated radiotherapy for supratentorial tumors.

Authors:  Shigeo Takahashi; Masahide Anada; Toshifumi Kinoshita; Takamasa Nishide; Shohei Kozai; Toru Shibata
Journal:  Mol Clin Oncol       Date:  2021-01-21

9.  Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome.

Authors:  Monique C Minnema; Eva Kimby; Shirley D'Sa; Luc-Matthieu Fornecker; Stéphanie Poulain; Tom J Snijders; Efstathios Kastritis; Stéphane Kremer; Aikaterini Fitsiori; Laurence Simon; Frédéric Davi; Michael Lunn; Jorge J Castillo; Christopher J Patterson; Magali Le Garff-Tavernier; Myrto Costopoulos; Véronique Leblond; Marie-José Kersten; Meletios A Dimopoulos; Steven P Treon
Journal:  Haematologica       Date:  2016-10-06       Impact factor: 9.941

10.  Control of brain metastases from radioresistant tumors treated by stereotactic radiosurgery.

Authors:  Andrew Yaeh; Tavish Nanda; Ashish Jani; Tzlil Rozenblat; Yasir Qureshi; Shumaila Saad; Jeraldine Lesser; Andrew B Lassman; Steven R Isaacson; Michael B Sisti; Jeffrey N Bruce; Guy M McKhann; Tony J C Wang
Journal:  J Neurooncol       Date:  2015-08-02       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.